(Q43809926)

English

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial

scientific article published on 18 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial (English)

1 reference

Europe PubMed Central

27 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Wenying Yang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jie Liu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zhongyan Shan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Haoming Tian

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Qiuhe Ji

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jianping Weng

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Weiping Jia

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Juming Lu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jing Liu

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yuan Xu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zhaojun Yang

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wei Chen

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

18 October 2013

1 reference

Europe PubMed Central

27 November 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

46-55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transculturalization of a diabetes-specific nutrition algorithm: Asian application

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanism of action of metformin: old or new insights?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970021-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(13)70021-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622668%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43809926&oldid=2103536861"